share_log
Moomoo 24/7 ·  04/11 08:05

Harmony Biosciences Announces Exclusive Agreement to Develop and Commercialize Tpm-1116, a Highly Potent and Selective Oral Orexin-2 Receptor Agonist

Harmony Biosciences宣布签订独家协议,开发和商业化Tpm-1116,一种高效的选择性口服Orexin-2受体激动剂

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发